| 02:49 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') - Update On Ongoing Tax Litigation Reported Earlier Under Integrated Filing (Governance)
|
| 06:40 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') - Update On Ongoing Tax Litigation Reported Under Integrated Filing (Governance)
|
| 05:46 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 02:17 PM |
Demat Status Report For The Month Of February 2026
|
| 12:41 PM |
Receipt Of Demand Order From The Office Of The Deputy Commissioner Of Income Tax, Delhi
|
| 04:03 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:50 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 07:57 PM |
Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2025
|
| 07:50 PM |
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2025
|
| 03:32 PM |
Details Of Shares Dematerialized During January 2026
Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 02:52 PM |
Outcome Of Inspection By National Centre For Public Health And Pharmacy, Hungary At Manufacturing Facility Of Panacea Biotec Pharma Limited At Baddi, Himachal Pradesh
|
| 03:42 PM |
Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31, 2025
|
| 06:36 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 04:49 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:45 PM |
Details Of Shares Dematerialized During December 2025
Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 06:10 PM |
Intimation Regarding Receipt Of Demand Order
|
| 05:54 PM |
Closure of Trading Window
|
| 05:09 PM |
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
|
| 06:54 PM |
Authorization Of Key Managerial Personnel For The Purpose Of Determining Materiality Of An Event Or Information &Making Disclosures To The Stock Exchange(S) Under The SEBI LODR Regulations
|
| 06:43 PM |
Appointment of Company Secretary and Compliance Officer
|
| 06:38 PM |
Announcement under Regulation 30 (LODR)-Cessation
|
| 06:34 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 03:11 PM |
Details Of Shares Dematerialized During November 2025
Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 06:08 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 06:03 PM |
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
|
| 12:56 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:24 PM |
Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2025
|
| 05:17 PM |
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2025
|
| 06:11 PM |
Intimation Regarding Change In Senior Management Personnel In The Company'S Material Wholly Owned Subsidiary Viz. Panacea Biotec Pharma Limited ('PBPL')
|
| 04:56 PM |
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
|
| 05:48 PM |
Details Of Shares Dematerialized During October, 2025
Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 04:40 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 05:29 PM |
Board Meeting Intimation for Approving Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Half Year Ended September 30, 2025
|
| 02:32 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 12:18 PM |
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
|
| 05:32 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 05:28 PM |
Demat Status Report For The Month Of September 2025
|
| 02:27 PM |
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
|
| 05:30 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 05:25 PM |
Shareholder Meeting / Postal Ballot-Outcome of AGM
|
| 04:40 PM |
Proceedings Of The 41St Annual General Meeting Held On September 30, 2025
|
| 03:32 PM |
Disclosure Under Regulation 30 Of SEBI LODR Regulations
|
| 04:14 PM |
Closure of Trading Window
|
| 06:17 PM |
Launch Of India'S First 100% Toxin-Free And Safe 'Nikomom' Baby Skin Care Products, And 'Staart Prime' Infant Milk Substitute Product By Company'S Wholly-Owned Subsidiary, Panacea Biotec Pharma Limited
|
| 06:09 PM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 04:41 PM |
Communication Sent To Physical Shareholders To Furnish PAN And KYC Details
|
| 03:19 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:56 PM |
Demat Status Report For The Month Of August 2025
|
| 05:43 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 04:37 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 04:34 PM |
Reg. 34 (1) Annual Report.
|
| 04:20 PM |
Intimation Of 41St Annual General Meeting Of The Company To Be Held On Tuesday, September 30, 2025 At 11:30 A.M. (IST) Through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM')
|
| 12:37 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:25 PM |
Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2025
|
| 05:41 PM |
Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2025
|
| 04:46 PM |
Demat Status Report For The Month Of July 2025
|
| 06:08 PM |
Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter Ended June 30, 2025
|
| 05:43 PM |
Intimation Under Regulation 30 And Regulation 31A(8) Of The Securities & Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations, 2015 - Approval For Reclassification Of Mrs. Sunanda Jain, Mr. Sumit Jain And Ms. Radhika Jain From 'Promoters & Promoters' Group' Category To 'Public' Category Of Panacea Biotec Limited
|
| 03:18 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:52 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 03:19 PM |
Intimation Of Settlement Of Disputes With Apotex Inc., Canada
Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 04:44 PM |
Details Of Shares Dematerialised During June 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 04:40 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 05:18 PM |
Closure of Trading Window
|
| 03:46 PM |
Details Of Shares Dematerialised During May, 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 11:19 AM |
Announcement under Regulation 30 (LODR)-Press Release / Media Release
|
| 03:30 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 08:37 PM |
Intimation Regarding Appointment Of Secretarial Auditor
|
| 08:24 PM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 08:22 PM |
Standalone And Consolidated Audited Financial Results Along With Auditors' Report For The Quarter And Financial Year Ended March 31, 2025
|
| 08:06 PM |
Board Meeting Outcome for 1. Standalone And Consolidated Audited Financial Results Along With Auditors' Report For The Quarter And Financial Year Ended March 31, 2025
2. Passing Over Of Dividend For The Financial Year 2024-25
3. Appointment Of Secretarial Auditor
|
| 03:36 PM |
Board Meeting Intimation for For Approval Of The Audited Financial Results For The Quarter And Financial Year Ended March 31, 2025 And Passing Over Of Dividend On Equity As Well As Preference Shares For The Said Financial Year.
|
| 05:48 PM |
Nation-Wide Study Undertaken By Panacea Biotec Pharma Ltd. (Material WOS) Confirms Chilrun Full Accelerates Growth And Development In Children
|
| 04:48 PM |
Details Of Shares Dematerialized During April 2025 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018
|
| 05:18 PM |
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
|
| 03:30 PM |
Receipt Of An Additional Award From UNICEF For Supply Of Bivalent Oral Polio Vaccine (Bopv) Worth ~US$ 5.20 Million In Q3 CY2025
|
| 04:34 PM |
Details Of Shares Dematerialized During March 2025
|
| 04:06 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 09:49 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 09:30 AM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 07:56 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
|
| 07:51 PM |
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
|
| 08:09 AM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 03:00 PM |
Closure of Trading Window
|
| 10:17 AM |
Clarification On Movement In Price
|
| 06:25 PM |
Clarification sought from Panacea Biotec Ltd
|
| 05:23 PM |
Demat Report For The Month Of February, 2025
|
| 05:32 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:26 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 01:59 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 12:12 AM |
Announcement under Regulation 30 (LODR)-Change in Directorate
|
| 07:40 PM |
Integrated Filing (Financial)
|
| 06:49 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 06:42 PM |
Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2024
|
| 06:32 PM |
Board Meeting Outcome for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2024
2. Appointment / Re-Appointment Of Directors
3. Change In Senior Management Personnel
4. Revision In Code Of Conduct For Prevention Of Insider Trading And Other Policies
|
| 05:19 PM |
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
|
| 03:49 PM |
Demat Report For The Month Of January, 2025
|
| 02:40 PM |
Board Meeting Intimation for Approval Of Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31, 2024
|
| 03:18 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback